‘Joining the dots’ – Newly appointed Group Marketing Director at CliniSys, Paul Jackson, provides an introduction and some initial observations

When you look at some of the stats from the CliniSys Group, our success is impressive.

  • CliniSys processes data for circa 60% of pathology in the UK and has leading market shares across Europe for Laboratory Information Management Systems.
  • The UK’s leading order communications platform – Integrated Clinical Environment (ICE), with over 40 million tests ordered by GPs each year and 35% of the acute sector market share. The software also underpins national NHS services such as England’s HPV screening

Such an impressive background and pedigree lays a great foundation for a senior marketer to build further at CliniSys. For this unassuming organisation, that quietly and efficiently developed solutions that have become the backbone of many healthcare systems across Europe, now is the time for CliniSys to step out of the shadows.

A graphic designer by trade, I have spent over 20 years working within healthcare IT supplier organisations developing and building their marketing infrastructure to maximise strategic and commercial goals. In its simplest form at CliniSys, it is about ‘joining the dots’ and bringing the organisation together as one powerful brand and voice. Marketing planning is already underway and starting in the first quarter of 2021 there will be a series of initiatives to support the CliniSys Group’s marketing and corporate goals.

‘Joining the dots’ already seems to be my common phrase for 2021. A positive consequence of 2020 was the significant improvement in the way we collaborate, and it will continue to develop in 2021. Also, 2020 drove our ability to look at things in a different way to maximise (and enhance) the benefit, by extending technology that already exists, so it can be applied further and wider across health and social care.  CliniSys has been adept at extending its existing technology and deployments to meet some of the most challenging aspects of the pandemic, specifically in support novel and mass testing and the rapid reporting of COVID-19 results back to key workers and citizens.

Whilst I am new in post, attributes that became quickly clear are the strength, determination, and passion right across the organisation to get the job done, even with the challenges that 2020 brought. Incorporate marketing into this and you can amplify those attributes and the outcomes further and wider.

The continued success of the CliniSys Group is also another mechanism that marketing will continue to use to strengthen the message. And it is not just about the ongoing contract wins, which are fantastic, but it is also about successful deployments or new product releases, and the tangible benefits and improvements they bring to our customers. Whether it be an individual deployment or network approach, our customer stories will continue to be told and shared. The recent launch of GLIMS Genomics in the UK has also been positively received and we are already speaking to several Genomic Laboratory Hubs and Local Genomic Laboratories.

2020 has reset many things and marketing is very much included, especially around physical face to face events, which are always an important part of the calendar. Marketers have had to change approaches and look at things in a completely different way, enabling the use of different media  and creative approaches. This will continue in 2021 and become adapted as another element of the marketer’s toolkit.

About the author

Paul Jackson

Group Marketing Director

Share this article:

Continue reading:

How Covid will shape the coming year and help to change pathology forever

Richard Craven, chief executive of CliniSys, considers how the tumultuous events of 2020 will impact on 2021, and how they will affect the company, the NHS, and the world of pathology for years to come. Twenty-twenty was an exceptional year. I doubt any of us will forget the arrival of the coronavirus or the impact […]

Read full article

A vision for diagnostic services across Scotland

The Integrated Clinical Environment, or ICE, is used in seven out of the 14 health boards in Scotland for order communications and results reporting. Imagine if it was used across Scotland, as a single point of information about tests of all kinds… At a recent webinar, CliniSys outlined the art of the possible.  “Today,” said […]

Read full article

West Yorkshire and Harrogate Pathology Network secures major contract for CliniSys LIMS

Design and implementation work is underway on the deployment of WinPath Enterprise to the ten labs in the West Yorkshire and Harrogate Pathology Network The hosted solution will support standardisation across the network that covers a patient population of 2.6 million and handles more than 50 million tests a year, ahead of the opening of […]

Read full article

Why genomics labs should look for bespoke LIMS, and not fall back on the EPR

CliniSys has brought GLIMS Genomics to the UK. In a launch webinar, experts explained how the new laboratory information system built for genomics labs can put them in charge of their IT, drive standardisation, and deliver reports that clinicians can use as they move into the exciting world of precision medicine. And Dr Fabienne Dufernez […]

Read full article

MIPS choisi par le gouvernement français pour contribuer à la prévention de l’épidémie de Covid-19

Dans le cadre de la gestion de l’épidémie, la détection et le traçage des cas positifs de Covid-19 sont déterminants pour la réussite de la sortie de crise et à la protection de la population française. C’est l’objectif du projet national SI-DEP, mis en place par le ministère des solidarités et de la santé, pour […]

Read full article
Share
Share
Share
Tweet
WhatsApp